{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T02:07:07Z","timestamp":1767060427052,"version":"3.48.0"},"reference-count":73,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T00:00:00Z","timestamp":1764115200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":34,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100012760","name":"Public Welfare Foundation","doi-asserted-by":"crossref","award":["JYY2023-14"],"award-info":[{"award-number":["JYY2023-14"]}],"id":[{"id":"10.13039\/100012760","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Natural Science Foundation of Beijing Municipality,China","award":["L234007"],"award-info":[{"award-number":["L234007"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82370087"],"award-info":[{"award-number":["82370087"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Discov Onc"],"DOI":"10.1007\/s12672-025-04000-1","type":"journal-article","created":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T17:37:27Z","timestamp":1764178647000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Predictive value of immunomodulatory-related genes for the prognosis of lung adenocarcinoma based on bioinformatics analysis"],"prefix":"10.1007","volume":"16","author":[{"given":"Luyu","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhimin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Yuanfang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teng","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dongchang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,26]]},"reference":[{"issue":"1","key":"4000_CR1","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1186\/s13046-021-02200-5","volume":"41","author":"L Ma","year":"2022","unstructured":"Ma L, Xue X, Zhang X, et al. The essential roles of m(6)A RNA modification to stimulate ENO1-dependent glycolysis and tumorigenesis in lung adenocarcinoma. J Exp Clin Cancer Res. 2022;41(1):36.","journal-title":"J Exp Clin Cancer Res"},{"issue":"7689","key":"4000_CR2","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1038\/nature25183","volume":"553","author":"RS Herbst","year":"2018","unstructured":"Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553(7689):446\u201354.","journal-title":"Nature"},{"key":"4000_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.876355","volume":"13","author":"X Zhang","year":"2022","unstructured":"Zhang X, Min S, Yang Y, et al. A TP53 related immune prognostic model for the prediction of clinical outcomes and therapeutic responses in lung adenocarcinoma. Front Immunol. 2022;13:876355.","journal-title":"Front Immunol"},{"key":"4000_CR4","doi-asserted-by":"publisher","DOI":"10.2174\/1874467217666230721123554","volume":"17","author":"XJ Qian","year":"2024","unstructured":"Qian XJ, Wang JW, Liu JB, et al. The mediating role of miR-451\/ETV4\/MMP13 signaling axis on epithelialmesenchymal transition in promoting non-small cell lung cancer progression. Curr Mol Pharmacol. 2024;17:e210723218988.","journal-title":"Curr Mol Pharmacol"},{"key":"4000_CR5","doi-asserted-by":"publisher","DOI":"10.2174\/0118761429269383231119062233","volume":"17","author":"A Ullah","year":"2024","unstructured":"Ullah A, Razzaq A, Alfaifi MY, et al. Sanguinarine attenuates lung cancer progression via oxidative stress-induced cell apoptosis. Curr Mol Pharmacol. 2024;17:e18761429269383.","journal-title":"Curr Mol Pharmacol"},{"issue":"2","key":"4000_CR6","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2174\/1874467215666220329212300","volume":"16","author":"Y Cai","year":"2023","unstructured":"Cai Y, Sheng Z, Dong Z, et al. EGFR inhibitor CL-387785 suppresses the progression of lung adenocarcinoma. Curr Mol Pharmacol. 2023;16(2):211\u20136.","journal-title":"Curr Mol Pharmacol"},{"issue":"14","key":"4000_CR7","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1056\/NEJMoa1917346","volume":"383","author":"RS Herbst","year":"2020","unstructured":"Herbst RS, Giaccone G, de Marinis F, et al. Atezolizumab for first-line treatment of PD-L1-selected patients with NSCLC. N Engl J Med. 2020;383(14):1328\u201339.","journal-title":"N Engl J Med"},{"issue":"1","key":"4000_CR8","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s12967-020-02233-y","volume":"18","author":"X Shi","year":"2020","unstructured":"Shi X, Li R, Dong X, et al. IRGS: an immune-related gene classifier for lung adenocarcinoma prognosis. J Transl Med. 2020;18(1):55.","journal-title":"J Transl Med"},{"issue":"1","key":"4000_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1186\/s13045-016-0277-y","volume":"9","author":"W Ma","year":"2016","unstructured":"Ma W, Gilligan BM, Yuan J, et al. Current status and perspectives in translational biomarker research for PD-1\/PD-L1 immune checkpoint blockade therapy. J Hematol Oncol. 2016;9(1):47.","journal-title":"J Hematol Oncol"},{"issue":"2","key":"4000_CR10","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1056\/NEJMra1703481","volume":"378","author":"MA Postow","year":"2018","unstructured":"Postow MA, Sidlow R, Hellmann MD. Immune-related adverse events associated with immune checkpoint blockade. N Engl J Med. 2018;378(2):158\u201368.","journal-title":"N Engl J Med"},{"issue":"1","key":"4000_CR11","first-page":"17","volume":"73","author":"RL Siegel","year":"2023","unstructured":"Siegel RL, Miller KD, Wagle NS, et al. Cancer statistics, 2023. CA Cancer J Clin. 2023;73(1):17\u201348.","journal-title":"CA Cancer J Clin"},{"issue":"1","key":"4000_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.cpan.2024.11.001","volume":"21","author":"J Chen","year":"2024","unstructured":"Chen J, Lin A, Luo P. Advancing pharmaceutical research: a comprehensive review of cutting-edge tools and technologies. Curr Pharm Anal. 2024;21(1):1\u201319.","journal-title":"Curr Pharm Anal"},{"issue":"1","key":"4000_CR13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.cpan.2024.12.002","volume":"21","author":"Y Liu","year":"2024","unstructured":"Liu Y, Zhang S, Liu K, et al. Advances in drug discovery based on network pharmacology and omics technology. Curr Pharm Anal. 2024;21(1):33\u201343.","journal-title":"Curr Pharm Anal"},{"key":"4000_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.gene.2020.145119","volume":"766","author":"L Yang","year":"2021","unstructured":"Yang L, Yang Y, Meng M, et al. Identification of prognosis-related genes in the cervical cancer immune microenvironment. Gene. 2021;766:145119.","journal-title":"Gene"},{"issue":"11","key":"4000_CR15","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1093\/jjco\/hyaa149","volume":"50","author":"M Someya","year":"2020","unstructured":"Someya M, Tsuchiya T, Fukushima Y, et al. Association between cancer immunity and treatment results in uterine cervical cancer patients treated with radiotherapy. Jpn J Clin Oncol. 2020;50(11):1290\u20137.","journal-title":"Jpn J Clin Oncol"},{"issue":"2","key":"4000_CR16","doi-asserted-by":"publisher","first-page":"233","DOI":"10.2174\/1386207323999200729113641","volume":"24","author":"N Li","year":"2021","unstructured":"Li N, Yu K, Lin Z, et al. Development and validation of a five-immune gene pair signature in endometrial carcinoma. Comb Chem High Throughput Screen. 2021;24(2):233\u201345.","journal-title":"Comb Chem High Throughput Screen"},{"issue":"6","key":"4000_CR17","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1200\/JCO.2010.30.5425","volume":"29","author":"B Mlecnik","year":"2011","unstructured":"Mlecnik B, Tosolini M, Kirilovsky A, et al. Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction. J Clin Oncol. 2011;29(6):610\u20138.","journal-title":"J Clin Oncol"},{"issue":"8","key":"4000_CR18","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv1507","volume":"44","author":"A Colaprico","year":"2016","unstructured":"Colaprico A, Silva TC, Olsen C, et al. TCGAbiolinks: an R\/Bioconductor package for integrative analysis of TCGA data. Nucleic Acids Res. 2016;44(8):e71.","journal-title":"Nucleic Acids Res"},{"issue":"6","key":"4000_CR19","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41587-020-0546-8","volume":"38","author":"MJ Goldman","year":"2020","unstructured":"Goldman MJ, Craft B, Hastie M, et al. Visualizing and interpreting cancer genomics data via the Xena platform. Nat Biotechnol. 2020;38(6):675\u20138.","journal-title":"Nat Biotechnol"},{"issue":"269","key":"4000_CR20","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6(269):pl1.","journal-title":"Sci Signal"},{"key":"4000_CR21","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.10008","volume":"8","author":"Z Zhao","year":"2020","unstructured":"Zhao Z, He B, Cai Q, et al. A model of twenty-three metabolic-related genes predicting overall survival for lung adenocarcinoma. PeerJ. 2020;8:e10008.","journal-title":"PeerJ"},{"issue":"5","key":"4000_CR22","doi-asserted-by":"crossref","first-page":"7028","DOI":"10.3892\/ol.2018.8296","volume":"15","author":"W Zhang","year":"2018","unstructured":"Zhang W, Fan J, Chen Q, et al. SPP1 and AGER as potential prognostic biomarkers for lung adenocarcinoma. Oncol Lett. 2018;15(5):7028\u201336.","journal-title":"Oncol Lett"},{"key":"4000_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.872910","volume":"13","author":"SL Peng","year":"2022","unstructured":"Peng SL, Wang R, Zhou YL, et al. Insight of a metabolic prognostic model to identify tumor environment and drug vulnerability for lung adenocarcinoma. Front Immunol. 2022;13:872910.","journal-title":"Front Immunol"},{"issue":"14","key":"4000_CR24","first-page":"1846","volume":"23","author":"S Davis","year":"2007","unstructured":"Davis S, Meltzer PS. GEOquery: a bridge between the Gene Expression Omnibus (GEO) and BioConductor. Bioinformatics (Oxford, England). 2007;23(14):1846\u20137.","journal-title":"Bioinformatics (Oxford, England)"},{"issue":"Database issue","key":"4000_CR25","doi-asserted-by":"publisher","first-page":"D760","DOI":"10.1093\/nar\/gkl887","volume":"35","author":"T Barrett","year":"2007","unstructured":"Barrett T, Troup DB, Wilhite SE, et al. NCBI GEO: mining tens of millions of expression profiles\u2013database and tools update. Nucleic Acids Res. 2007;35(Database issue):D760\u20135.","journal-title":"Nucleic Acids Res"},{"key":"4000_CR26","first-page":"1.30.1","volume":"54","author":"G Stelzer","year":"2016","unstructured":"Stelzer G, Rosen N, Plaschkes I, et al. The GeneCards suite: from gene data mining to disease genome sequence analyses. Curr Prot Bioinform. 2016;54:1.30.1-1.3.","journal-title":"Curr Prot Bioinform"},{"key":"4000_CR27","doi-asserted-by":"publisher","DOI":"10.1155\/2022\/5242437","volume":"2022","author":"C Gu","year":"2022","unstructured":"Gu C, Chang W, Wu J, et al. NCOA4: an immunomodulation-related prognostic biomarker in colon adenocarcinoma and pan-cancer. J Oncol. 2022;2022:5242437.","journal-title":"J Oncol"},{"issue":"1","key":"4000_CR28","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1186\/s12885-022-09654-6","volume":"22","author":"H Ma","year":"2022","unstructured":"Ma H, Feng PH, Yu SN, et al. Identification and validation of TNFRSF4 as a high-profile biomarker for prognosis and immunomodulation in endometrial carcinoma. BMC Cancer. 2022;22(1):543.","journal-title":"BMC Cancer"},{"issue":"7","key":"4000_CR29","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, et al. Limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43(7):e47.","journal-title":"Nucleic Acids Res"},{"key":"4000_CR30","doi-asserted-by":"publisher","first-page":"1018639","DOI":"10.3389\/fendo.2022.1018639","volume":"13","author":"Z Zhao","year":"2022","unstructured":"Zhao Z, Yang H, Ji G, et al. Identification of hub genes for early detection of bone metastasis in breast cancer. Front Endocrinol. 2022;13:1018639.","journal-title":"Front Endocrinol"},{"issue":"11","key":"4000_CR31","first-page":"3553","volume":"22","author":"GM Li","year":"2018","unstructured":"Li GM, Zhang CL, Rui RP, et al. Bioinformatics analysis of common differential genes of coronary artery disease and ischemic cardiomyopathy. Eur Rev Med Pharmacol Sci. 2018;22(11):3553\u201369.","journal-title":"Eur Rev Med Pharmacol Sci"},{"issue":"11","key":"4000_CR32","doi-asserted-by":"publisher","first-page":"1747","DOI":"10.1101\/gr.239244.118","volume":"28","author":"A Mayakonda","year":"2018","unstructured":"Mayakonda A, Lin DC, Assenov Y, et al. Maftools: efficient and comprehensive analysis of somatic variants in cancer. Genome Res. 2018;28(11):1747\u201356.","journal-title":"Genome Res"},{"issue":"7","key":"4000_CR33","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1093\/bioinformatics\/btq064","volume":"26","author":"G Yu","year":"2010","unstructured":"Yu G, Li F, Qin Y, et al. GOsemSim: an R package for measuring semantic similarity among GO terms and gene products. Bioinformatics. 2010;26(7):976\u20138.","journal-title":"Bioinformatics"},{"issue":"1","key":"4000_CR34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27\u201330.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"4000_CR35","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, et al. ClusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137.","journal-title":"OMICS"},{"issue":"43","key":"4000_CR36","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102(43):15545\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"4000_CR37","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1186\/s12859-021-04279-1","volume":"22","author":"G Bri\u00e8re","year":"2021","unstructured":"Bri\u00e8re G, Darbo \u00c9, Th\u00e9bault P, et al. Consensus clustering applied to multi-omics disease subtyping. BMC Bioinform. 2021;22(1):361.","journal-title":"BMC Bioinform"},{"issue":"12","key":"4000_CR38","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26(12):1572\u20133.","journal-title":"Bioinformatics"},{"issue":"4","key":"4000_CR39","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","volume":"39","author":"G Bindea","year":"2013","unstructured":"Bindea G, Mlecnik B, Tosolini M, et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. 2013;39(4):782\u201395.","journal-title":"Immunity"},{"issue":"1","key":"4000_CR40","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong P, Finotello F, Angelova M, et al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep. 2017;18(1):248\u201362.","journal-title":"Cell Rep"},{"key":"4000_CR41","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4NZELMANN","year":"2013","unstructured":"H\u00e4NZELMANN S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"issue":"2","key":"4000_CR42","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1002\/path.2931","volume":"225","author":"HQ Wang","year":"2011","unstructured":"Wang HQ, Yu XD, Liu ZH, et al. Deregulated miR-155 promotes Fas-mediated apoptosis in human intervertebral disc degeneration by targeting FADD and caspase-3. J Pathol. 2011;225(2):232\u201342.","journal-title":"J Pathol"},{"issue":"6","key":"4000_CR43","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsd\u00f3ttir H, et al. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1(6):417\u201325.","journal-title":"Cell Syst"},{"issue":"1","key":"4000_CR44","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-019-0730-1","volume":"11","author":"S Engebretsen","year":"2019","unstructured":"Engebretsen S, Bohlin J. Statistical predictions with glmnet. Clin Epigenetics. 2019;11(1):123.","journal-title":"Clin Epigenetics"},{"key":"4000_CR45","doi-asserted-by":"publisher","DOI":"10.1515\/ijb-2017-0070","author":"W Cai","year":"2020","unstructured":"Cai W, van der Laan M. Nonparametric bootstrap inference for the targeted highly adaptive least absolute shrinkage and selection operator (LASSO) estimator. Int J Biostat. 2020. https:\/\/doi.org\/10.1515\/ijb-2017-0070.","journal-title":"Int J Biostat"},{"issue":"4","key":"4000_CR46","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1016\/j.jtcvs.2017.12.107","volume":"155","author":"SY Park","year":"2018","unstructured":"Park SY. Nomogram: an analogue tool to deliver digital knowledge. J Thorac Cardiovasc Surg. 2018;155(4):1793.","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"2","key":"4000_CR47","doi-asserted-by":"publisher","first-page":"S3","DOI":"10.1097\/EDE.0000000000001094","volume":"30","author":"NJ Perkins","year":"2019","unstructured":"Perkins NJ, Weck J, Mumford SL, et al. Combining biomarker calibration data to reduce measurement error. Epidemiology. 2019;30(2):S3-s9.","journal-title":"Epidemiology"},{"issue":"6","key":"4000_CR48","doi-asserted-by":"publisher","first-page":"796","DOI":"10.1016\/j.eururo.2018.08.038","volume":"74","author":"B van Calster","year":"2018","unstructured":"van Calster B, Wynants L, Verbeek JFM, et al. Reporting and interpreting decision curve analysis: a guide for investigators. Eur Urol. 2018;74(6):796\u2013804.","journal-title":"Eur Urol"},{"issue":"8","key":"4000_CR49","doi-asserted-by":"publisher","first-page":"1623","DOI":"10.1016\/j.mayocp.2019.01.013","volume":"94","author":"N Duma","year":"2019","unstructured":"Duma N, Santana-Davila R, Molina JR. Non-small cell lung cancer: epidemiology, screening, diagnosis, and treatment. Mayo Clin Proc. 2019;94(8):1623\u201340.","journal-title":"Mayo Clin Proc"},{"issue":"11","key":"4000_CR50","doi-asserted-by":"publisher","first-page":"3015","DOI":"10.1172\/JCI28898","volume":"116","author":"H Shi","year":"2006","unstructured":"Shi H, Kokoeva MV, Inouye K, et al. TLR4 links innate immunity and fatty acid-induced insulin resistance. J Clin Invest. 2006;116(11):3015\u201325.","journal-title":"J Clin Invest"},{"issue":"11","key":"4000_CR51","doi-asserted-by":"publisher","first-page":"2850","DOI":"10.1016\/j.molimm.2007.01.022","volume":"44","author":"W He","year":"2007","unstructured":"He W, Liu Q, Wang L, et al. TLR4 signaling promotes immune escape of human lung cancer cells by inducing immunosuppressive cytokines and apoptosis resistance. Mol Immunol. 2007;44(11):2850\u20139.","journal-title":"Mol Immunol"},{"issue":"6","key":"4000_CR52","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1007\/s11033-008-9338-9","volume":"36","author":"YB Zhang","year":"2009","unstructured":"Zhang YB, He FL, Fang M, et al. Increased expression of Toll-like receptors 4 and 9 in human lung cancer. Mol Biol Rep. 2009;36(6):1475\u201381.","journal-title":"Mol Biol Rep"},{"issue":"9","key":"4000_CR53","doi-asserted-by":"publisher","first-page":"2473","DOI":"10.1111\/1759-7714.13558","volume":"11","author":"H Du","year":"2020","unstructured":"Du H, Li Y, Sun R, et al. CEACAM6 promotes cisplatin resistance in lung adenocarcinoma and is regulated by microRNA-146a and microRNA-26a. Thorac Cancer. 2020;11(9):2473\u201382.","journal-title":"Thorac Cancer"},{"key":"4000_CR54","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.canlet.2020.04.001","volume":"483","author":"R Jin","year":"2020","unstructured":"Jin R, Wang X, Zang R, et al. Desmoglein-2 modulates tumor progression and osimertinib drug resistance through the EGFR\/Src\/PAK1 pathway in lung adenocarcinoma. Cancer Lett. 2020;483:46\u201358.","journal-title":"Cancer Lett"},{"issue":"7","key":"4000_CR55","volume":"16","author":"AV Rompou","year":"2024","unstructured":"Rompou AV, Bletsa G, Tsakogiannis D, et al. An updated review of resistin and colorectal cancer. Cureus. 2024;16(7):e65403.","journal-title":"Cureus"},{"issue":"8","key":"4000_CR56","doi-asserted-by":"publisher","first-page":"2631","DOI":"10.7150\/jca.70725","volume":"13","author":"H Huang","year":"2022","unstructured":"Huang H, Zhu G, Shi R, et al. Development and validation of a combined hypoxia and immune prognostic classifier for lung adenocarcinoma. J Cancer. 2022;13(8):2631\u201343.","journal-title":"J Cancer"},{"issue":"2","key":"4000_CR57","doi-asserted-by":"publisher","first-page":"522","DOI":"10.7150\/ijbs.67556","volume":"18","author":"Z Chen","year":"2022","unstructured":"Chen Z, Hu Z, Sui Q, et al. LncRNA FAM83A-AS1 facilitates tumor proliferation and the migration via the HIF-1\u03b1\/ glycolysis axis in lung adenocarcinoma. Int J Biol Sci. 2022;18(2):522\u201335.","journal-title":"Int J Biol Sci"},{"key":"4000_CR58","doi-asserted-by":"publisher","first-page":"1013238","DOI":"10.3389\/fendo.2022.1013238","volume":"13","author":"YH Zhang","year":"2022","unstructured":"Zhang YH, Zeng J, Liu XS, et al. ECE2 is a prognostic biomarker associated with m6A modification and involved in immune infiltration of lung adenocarcinoma. Front Endocrinol. 2022;13:1013238.","journal-title":"Front Endocrinol"},{"key":"4000_CR59","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1146\/annurev-immunol-061020-053707","volume":"39","author":"M Cabeza-Cabrerizo","year":"2021","unstructured":"Cabeza-Cabrerizo M, Cardoso A, Minutti CM, et al. Dendritic cells revisited. Annu Rev Immunol. 2021;39:131\u201366.","journal-title":"Annu Rev Immunol"},{"issue":"1","key":"4000_CR60","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1038\/s41577-019-0210-z","volume":"20","author":"SK Wculek","year":"2020","unstructured":"Wculek SK, Cueto FJ, Mujal AM, et al. Dendritic cells in cancer immunology and immunotherapy. Nat Rev Immunol. 2020;20(1):7\u201324.","journal-title":"Nat Rev Immunol"},{"key":"4000_CR61","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.743050","volume":"11","author":"R Chen","year":"2021","unstructured":"Chen R, Huang M, Yang X, et al. CALR-TLR4 complex inhibits non-small cell lung cancer progression by regulating the migration and maturation of dendritic cells. Front Oncol. 2021;11:743050.","journal-title":"Front Oncol"},{"issue":"10135","key":"4000_CR62","doi-asserted-by":"publisher","first-page":"2128","DOI":"10.1016\/S0140-6736(18)30789-X","volume":"391","author":"F PAG\u00e8S","year":"2018","unstructured":"PAG\u00e8S F, Mlecnik B, Marliot F, et al. International validation of the consensus immunoscore for the classification of colon cancer: a prognostic and accuracy study. Lancet (London, England). 2018;391(10135):2128\u201339.","journal-title":"Lancet (London, England)"},{"issue":"73","key":"4000_CR63","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abq2630","volume":"7","author":"H Kwon","year":"2022","unstructured":"Kwon H, Schafer JM, Song NJ, et al. Androgen conspires with the CD8(+) T cell exhaustion program and contributes to sex bias in cancer. Sci Immunol. 2022;7(73):eabq2630.","journal-title":"Sci Immunol"},{"key":"4000_CR64","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179319","author":"BL Justo","year":"2021","unstructured":"Justo BL, Jasiulionis MG. Characteristics of TIMP1, CD63, and \u03b21-integrin and the functional impact of their interaction in cancer. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms22179319.","journal-title":"Int J Mol Sci"},{"issue":"4","key":"4000_CR65","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1593\/tlo.09220","volume":"2","author":"TI Ricca","year":"2009","unstructured":"Ricca TI, Liang G, Suenaga AP, et al. Tissue inhibitor of metalloproteinase 1 expression associated with gene demethylation confers anoikis resistance in early phases of melanocyte malignant transformation. Transl Oncol. 2009;2(4):329\u201340.","journal-title":"Transl Oncol"},{"issue":"8","key":"4000_CR66","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2023.e18503","volume":"9","author":"Q Zhang","year":"2023","unstructured":"Zhang Q, Zhao M, Lin S, et al. Prediction of prognosis and immunotherapy response in lung adenocarcinoma based on CD79A, DKK1 and VEGFC. Heliyon. 2023;9(8):e18503.","journal-title":"Heliyon"},{"issue":"10","key":"4000_CR67","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.bcp.2011.06.007","volume":"82","author":"C Glorieux","year":"2011","unstructured":"Glorieux C, Dejeans N, Sid B, et al. Catalase overexpression in mammary cancer cells leads to a less aggressive phenotype and an altered response to chemotherapy. Biochem Pharmacol. 2011;82(10):1384\u201390.","journal-title":"Biochem Pharmacol"},{"key":"4000_CR68","doi-asserted-by":"publisher","first-page":"1119837","DOI":"10.3389\/fphar.2023.1119837","volume":"14","author":"JS Liu","year":"2023","unstructured":"Liu JS, Liu JY, Xiao Q, et al. Association of variations in the CAT and prognosis in lung cancer patients with platinum-based chemotherapy. Front Pharmacol. 2023;14:1119837.","journal-title":"Front Pharmacol"},{"key":"4000_CR69","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.ebiom.2019.08.037","volume":"48","author":"M Zhan","year":"2019","unstructured":"Zhan M, Wang H, Xu SW, et al. Variants in oxidative stress-related genes affect the chemosensitivity through Nrf2-mediated signaling pathway in biliary tract cancer. EBioMedicine. 2019;48:143\u201360.","journal-title":"EBioMedicine"},{"issue":"24","key":"4000_CR70","doi-asserted-by":"publisher","first-page":"6987","DOI":"10.1158\/0008-5472.CAN-17-1701","volume":"77","author":"JT Goldstein","year":"2017","unstructured":"Goldstein JT, Berger AC, Shih J, et al. Genomic activation of PPARG reveals a candidate therapeutic axis in bladder cancer. Cancer Res. 2017;77(24):6987\u201398.","journal-title":"Cancer Res"},{"issue":"8","key":"4000_CR71","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1038\/sj.onc.1208333","volume":"24","author":"Y Bren-Mattison","year":"2005","unstructured":"Bren-Mattison Y, van Putten V, Chan D, et al. Peroxisome proliferator-activated receptor-gamma (PPAR(gamma)) inhibits tumorigenesis by reversing the undifferentiated phenotype of metastatic non-small-cell lung cancer cells (NSCLC). Oncogene. 2005;24(8):1412\u201322.","journal-title":"Oncogene"},{"issue":"1","key":"4000_CR72","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/s41420-022-01055-9","volume":"8","author":"X Song","year":"2022","unstructured":"Song X, Chen B, Liang Y, et al. Circeif3h-IGF2BP2-HuR scaffold complex promotes TNBC progression via stabilizing HSPD1\/RBM8A\/G3BP1 mRNA. Cell Death Discov. 2022;8(1):261.","journal-title":"Cell Death Discov"},{"issue":"1","key":"4000_CR73","doi-asserted-by":"publisher","first-page":"85","DOI":"10.3233\/CBM-200410","volume":"30","author":"Y Tang","year":"2021","unstructured":"Tang Y, Yang Y, Luo J, et al. Overexpression of HSP10 correlates with HSP60 and Mcl-1 levels and predicts poor prognosis in non-small cell lung cancer patients. Cancer Biomark. 2021;30(1):85\u201394.","journal-title":"Cancer Biomark"}],"container-title":["Discover Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-04000-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12672-025-04000-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12672-025-04000-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T02:02:23Z","timestamp":1767060143000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12672-025-04000-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,26]]},"references-count":73,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["4000"],"URL":"https:\/\/doi.org\/10.1007\/s12672-025-04000-1","relation":{},"ISSN":["2730-6011"],"issn-type":[{"type":"electronic","value":"2730-6011"}],"subject":[],"published":{"date-parts":[[2025,11,26]]},"assertion":[{"value":"10 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study employed secondary de-identified genomic data from public repositories (TCGA\/GEO). All publicly available data used in this study were sourced from previously published research. The study was exempt from ethical approval by the Beijing Chest Hospital Ethics Committee. All analyses were performed in accordance with the ethical principles of the Helsinki Declaration.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors have approved the manuscript and agree with its submission to the journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"2304"}}